Search by Drug Name or NDC

    NDC 00078-0698-99 RYDAPT 25 mg/1 Details

    RYDAPT 25 mg/1

    RYDAPT is a ORAL CAPSULE, LIQUID FILLED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is MIDOSTAURIN.

    Product Information

    NDC 00078-0698
    Product ID 0078-0698_d33f12ce-c74d-487e-81db-86fd5c265c94
    Associated GPIs 21533030000130
    GCN Sequence Number 077344
    GCN Sequence Number Description midostaurin CAPSULE 25 MG ORAL
    HIC3 V1Q
    HIC3 Description ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS
    GCN 43327
    HICL Sequence Number 044227
    HICL Sequence Number Description MIDOSTAURIN
    Brand/Generic Brand
    Proprietary Name RYDAPT
    Proprietary Name Suffix n/a
    Non-Proprietary Name RYDAPT
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, LIQUID FILLED
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name MIDOSTAURIN
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Kinase Inhibitor [EPC], Receptor Tyrosine Kinase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207997
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0698-99 (00078069899)

    NDC Package Code 0078-0698-99
    Billing NDC 00078069899
    Package 2 CARTON in 1 CARTON (0078-0698-99) / 14 BLISTER PACK in 1 CARTON (0078-0698-51) / 2 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (0078-0698-02)
    Marketing Start Date 2017-04-28
    NDC Exclude Flag N
    Pricing Information N/A